Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Phillips-Medisize A/S - Group Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmarkIFRS Analyst: XBRLDenmarkIFRS

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   29.4% 29.0% 29.0% 0.0% 0.4% 0.4% 4.1% 4.0%   Credit score (0-100)   2 3 2 0 100 100 49 49   Credit rating   C B B N/A AAA AAA BBB BBB   Credit limit (mDKK)   0.0 0.0 0.0 0.0 25.5 43.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 378 482 482 482   Gross profit   0.0 0.0 0.0 0.0 91.8 171 0.0 0.0   EBITDA   0.0 0.0 0.0 0.0 64.5 113 0.0 0.0   EBIT   0.0 0.0 0.0 0.0 64.5 113 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 0.0 0.0 64.7 110.4 0.0 0.0   Net earnings   0.0 0.0 0.0 0.0 49.2 83.4 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 0.0 0.0 64.7 110 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 43.8 44.5 0.0 0.0   Shareholders equity total   0.0 0.0 0.0 0.0 158 241 84.6 84.6   Interest-bearing liabilities   0.0 0.0 0.0 0.0 59.6 22.8 0.0 0.0   Balance sheet total (assets)   0.0 0.0 0.0 0.0 321 385 84.6 84.6   Net Debt   0.0 0.0 0.0 0.0 -43.4 -209 -83.7 -83.7     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 378 482 482 482   Net sales growth   -100.0% 0.0% 0.0% 0.0% 0.0% 27.5% 0.0% 0.0%   Gross profit   0.0 0.0 0.0 0.0 91.8 171 0.0 0.0   Gross profit growth   -100.0% 0.0% 0.0% 0.0% 0.0% 86.2% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 0 0 321 385 85 85   Balance sheet change%   -100.0% 0.0% 0.0% 0.0% 0.0% 20.1% -78.0% 0.0%   Added value   0.0 0.0 0.0 0.0 64.5 113.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 17.1% 23.5% 0.0% 0.0%   Investments   -11 0 0 0 45 0 -45 0   Net sales trend   -2.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0   EBIT trend   0.0 0.0 0.0 0.0 1.0 2.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 17.1% 23.5% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 17.1% 23.5% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 0.0% 0.0% 70.2% 66.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 13.0% 17.3% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 13.0% 17.3% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 17.1% 22.9% 0.0% 0.0%   ROA %   0.0% 0.0% 0.0% 0.0% 21.1% 33.8% 0.0% 0.0%   ROI %   0.0% 0.0% 0.0% 0.0% 30.9% 47.0% 0.0% 0.0%   ROE %   0.0% 0.0% 0.0% 0.0% 31.1% 41.8% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% 0.0% 0.0% 61.6% 71.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 43.1% 29.9% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 15.9% -18.2% -17.4% -17.4%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% 0.0% -67.3% -184.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 37.7% 9.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 10.5% 21.6% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.0 0.0 2.5 3.2 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.0 1.7 2.4 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 103.0 231.7 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 1.0 55.5 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 72.4% 70.3% 17.4% 17.4%   Net working capital   0.0 0.0 0.0 0.0 112.8 196.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 29.9% 40.7% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 N/A 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0